Where does Nellone Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nellone Therapeutics, Inc. ranks #49,010 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nellone Therapeutics, Inc. hold?

Nellone Therapeutics, Inc. holds 5 US utility patents granted between 2020 and 2025, spanning 2 technology areas.

What is Nellone Therapeutics, Inc.'s Innovation Score?

Nellone Therapeutics, Inc. has an Innovation Score of 32.4 out of 100 (41st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Nellone Therapeutics, Inc. focus on?

Nellone Therapeutics, Inc.'s top technology area is C07K (Peptides) with 5 patents, ranking #1,584 of 3,615 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

Is Nellone Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Nellone Therapeutics, Inc..

What does claim depth mean for Nellone Therapeutics, Inc.'s patents?

Nellone Therapeutics, Inc.'s patents average 24.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nellone Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Nellone Therapeutics, Inc.

USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nellone ranks #49,010 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.

#49,010
of 49,997 US assignees by volume: 41st percentile
by Innovation Score (32.4/100): 24.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R49010 · US Corporation #49,010 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #49,010/49,997
PHOTO-FINISH NEC Infrontia
CPC-NARROW C07K · 2 areas
INNOV-THIN 32.4/100
CLAIMS-DENSE 24.2 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: NEC Infrontia Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nellone’s 32.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (19%) Velocity 6.7 pts (21%) Breadth 5.0 pts (15%) Claim depth 14.5 pts (45%)

Qualcomm Incorporated · highest

85
Nellone Therapeutics · this assignee

32
3D Lighting… · lowest

7

What this shows Nellone's Innovation Score is 32.4/100 (41st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Nellone?

Each dot is one of Nellone’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nellone’s own 24.2 claims/patent is ABOVE the 15.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Nellone vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nellone's grants concentrate

Nellone Therapeutics, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under C07K (Peptides). By volume, Nellone sits between NEC Infrontia Corporation and Neovasc Medical Ltd..

Nellone's three-year grant acceleration

Nellone Therapeutics, Inc. shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

NEC Infrontia

5
Needstomatch

5
Nefab AB

5
Nektium Pharma S L

5
Nemo Arms

5
NEO G

5
Neosurgical

5
Neovasc Medical

5
Nellone Therapeut… ◀

5

What this shows Nellone holds 5 patents at rank #48,985, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nellone

By rank, the assignees closest to #48,985 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Nellone's primary technology class.

Nellone's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 41st percentile higher than 41% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Nellone Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	20.0%
2021	1	20.0%
2023	1	20.0%
2024	1	20.0%
2025partial year	1	20.0%

Which technologies does Nellone Therapeutics, Inc. patent most?

C07K - Peptides 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Nellone Therapeutics, Inc.'s patent record in context - here's where to go next.

Nellone Therapeutics, Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #49,010 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nellone Therapeutics, Inc. against NEC Infrontia Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.